These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Inverse correlation of epidermal growth factor receptor messenger RNA induction and suppression of anchorage-independent growth by OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in glioblastoma multiforme cell lines. Halatsch ME; Gehrke EE; Vougioukas VI; Bötefür IC; A-Borhani F; Efferth T; Gebhart E; Domhof S; Schmidt U; Buchfelder M J Neurosurg; 2004 Mar; 100(3):523-33. PubMed ID: 15035290 [TBL] [Abstract][Full Text] [Related]
7. Marked inhibition of glioblastoma target cell tumorigenicity in vitro by retrovirus-mediated transfer of a hairpin ribozyme against deletion-mutant epidermal growth factor receptor messenger RNA. Halatsch ME; Schmidt U; Bötefür IC; Holland JF; Ohnuma T J Neurosurg; 2000 Feb; 92(2):297-305. PubMed ID: 10659018 [TBL] [Abstract][Full Text] [Related]
8. Molecular features of adult glioma associated with patient race/ethnicity, age, and a polymorphism in O6-methylguanine-DNA-methyltransferase. Wiencke JK; Aldape K; McMillan A; Wiemels J; Moghadassi M; Miike R; Kelsey KT; Patoka J; Long J; Wrensch M Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1774-83. PubMed ID: 16030116 [TBL] [Abstract][Full Text] [Related]
9. Discordance between accumulated p53 protein level and its transcriptional activity in response to u.v. radiation. Lu X; Burbidge SA; Griffin S; Smith HM Oncogene; 1996 Jul; 13(2):413-8. PubMed ID: 8710381 [TBL] [Abstract][Full Text] [Related]
10. A comparative study of epidermal growth factor receptor (EGFR) and MDM2 gene amplification and protein immunoreactivity in human glioblastomas. Rieske P; Kordek R; Bartkowiak J; Debiec-Rychter M; Biernat W; Liberski PP Pol J Pathol; 1998; 49(3):145-9. PubMed ID: 9810172 [TBL] [Abstract][Full Text] [Related]
11. [Study on the expression of epidermal growth factor receptor and p53 in astrocytic gliomas: evidence for a distinct genetic pathway]. Dong L; Pu PY; Wang H; Wang GX; Kang CS; Jiao DR Zhonghua Bing Li Xue Za Zhi; 2006 Apr; 35(4):232-6. PubMed ID: 16776982 [TBL] [Abstract][Full Text] [Related]
12. Mutations of TP53, amplification of EGFR, MDM2 and CDK4, and deletions of CDKN2A in malignant astrocytomas. Biernat W; Debiec-Rychter M; Liberski PP Pol J Pathol; 1998; 49(4):267-71. PubMed ID: 10323080 [TBL] [Abstract][Full Text] [Related]
13. p53 gene mutation and ink4a-arf deletion appear to be two mutually exclusive events in human glioblastoma. Fulci G; Labuhn M; Maier D; Lachat Y; Hausmann O; Hegi ME; Janzer RC; Merlo A; Van Meir EG Oncogene; 2000 Aug; 19(33):3816-22. PubMed ID: 10949938 [TBL] [Abstract][Full Text] [Related]
14. Selective compartmentalization of different mdm2 proteins within the nucleus. Maxwell SA Anticancer Res; 1994; 14(6B):2541-7. PubMed ID: 7872679 [TBL] [Abstract][Full Text] [Related]
15. The high levels of p53 present in adenovirus early region 1-transformed human cells do not cause up-regulation of MDM2 expression. Grand RJ; Lecane PS; Owen D; Grant ML; Roberts S; Levine AJ; Gallimore PH Virology; 1995 Jul; 210(2):323-34. PubMed ID: 7618270 [TBL] [Abstract][Full Text] [Related]
16. An abnormality in the p53 pathway following gamma-irradiation in many wild-type p53 human melanoma lines. Bae I; Smith ML; Sheikh MS; Zhan Q; Scudiero DA; Friend SH; O'Connor PM; Fornace AJ Cancer Res; 1996 Feb; 56(4):840-7. PubMed ID: 8631022 [TBL] [Abstract][Full Text] [Related]
17. Expression of alternatively spliced mdm2 transcripts correlates with stabilized wild-type p53 protein in human glioblastoma cells. Kraus A; Neff F; Behn M; Schuermann M; Muenkel K; Schlegel J Int J Cancer; 1999 Mar; 80(6):930-4. PubMed ID: 10074928 [TBL] [Abstract][Full Text] [Related]
18. Differential expression of multiple MDM2 messenger RNAs and proteins in normal and tumorigenic breast epithelial cells. Gudas JM; Nguyen H; Klein RC; Katayose D; Seth P; Cowan KH Clin Cancer Res; 1995 Jan; 1(1):71-80. PubMed ID: 9815889 [TBL] [Abstract][Full Text] [Related]
19. Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents. O'Connor PM; Jackman J; Bae I; Myers TG; Fan S; Mutoh M; Scudiero DA; Monks A; Sausville EA; Weinstein JN; Friend S; Fornace AJ; Kohn KW Cancer Res; 1997 Oct; 57(19):4285-300. PubMed ID: 9331090 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of MDM2, due to enhanced translation, results in inactivation of wild-type p53 in Burkitt's lymphoma cells. Capoulade C; Bressac-de Paillerets B; Lefrère I; Ronsin M; Feunteun J; Tursz T; Wiels J Oncogene; 1998 Mar; 16(12):1603-10. PubMed ID: 9569028 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]